Evicenter
Keytruda (pembrolizumab) in High-risk early-stage triple-negative breast cancer
Manufacturer
Merck Sharp & Dohme LLC
Prescribing information
Keytruda (opens in a new tab)
Questions
28
Last updated

All questions

Pharmacology: Keytruda (pembrolizumab) in high-risk early-stage triple-negative breast cancer

3 questions · 2 sources